Organisation: Quest Diagnostics

IAM’s Market Makers of 2023

Via Licensing Alliance’s Heath Hoglund takes the top spot in our annual ranking of the patent market’s most innovative and influential deal makers and decision takers

14 March 2024

Natera’s $96 million win is latest big-money decision in contested cell-free DNA testing space

The major victory comes just days after the company was ordered to hand over $57 million in another dispute

02 February 2024

Ravgen notches up another David-v-Goliath victory with $57 million damages award

But the outcome is bitter-sweet for the SME, which has faced many obstacles in its quest to enforce its foundational patents

18 January 2024

Ravgen assertion campaign highlights problems with US patent reforms

The diagnostics innovator has bagged a further $100 million in damages, but the country’s patent system has put unnecessary hurdles in the way, argues representative John Desmarais.

25 May 2023

Ravgen continues winning streak in big-money patent assertion campaign

Illumina settlement and clean sweep at the PTAB have added to earlier $273 million damages award

26 April 2023

Waco jury awards $273 million damages in first battle of David-v-Goliaths licensing campaign

Ravgen is pursuing several large diagnostics companies in patent enforcement drive

04 October 2022

Investment in medical device IP is surging

Diagnostic innovation buyouts drive resurgence of med-tech deal-making

19 October 2021